DePuy expands range with two distribution deals
This article was originally published in Clinica
Executive Summary
Orthopaedics company DePuy, a subsidiary of Johnson & Johnson, is to expand its business through two distribution deals. The first, with Bio-Technology General (BTG), will bring it a hyaluronic product for the treatment of pain due to osteoarthritis of the knee. In the second transaction the company gains access to Etex' bone substitute material. The Etex deal includes a joint R&D agreement for future products.